 | • レポートコード：MRC2-11QY12710 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はミトコンドリアミオパチーのグローバル市場について調査・分析したレポートです。種類別（筋肉生検、血液酵素検査、遺伝子検査）市場規模、用途別（病院、クリニック、疾病研究・開発機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ミトコンドリアミオパチーの競争状況、市場シェア ・世界のミトコンドリアミオパチー市場：種類別市場規模 2015年-2020年（筋肉生検、血液酵素検査、遺伝子検査） ・世界のミトコンドリアミオパチー市場：種類別市場規模予測 2021年-2026年（筋肉生検、血液酵素検査、遺伝子検査） ・世界のミトコンドリアミオパチー市場：用途別市場規模 2015年-2020年（病院、クリニック、疾病研究・開発機関） ・世界のミトコンドリアミオパチー市場：用途別市場規模予測 2021年-2026年（病院、クリニック、疾病研究・開発機関） ・北米のミトコンドリアミオパチー市場分析：米国、カナダ ・ヨーロッパのミトコンドリアミオパチー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのミトコンドリアミオパチー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のミトコンドリアミオパチー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのミトコンドリアミオパチー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Reata Pharmaceuticals、Stealth Biotherapeutics、Raptor Pharmaceutical、Raym Genedx、Neurovive Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate “ragged red” muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an increased reactivity for succinate dehydrogenase and a decreased reactivity for cytochrome c oxidase.
The identification of patients with possible MM depends upon the investigation of multiple organ dysfunction in the clinical history, examination, and clinical tests. Although there is no disease-modifying therapy for MM, there are numerous points of clinical relevance that can reduce morbidity and improve quality of life for patients with these disorders.
Market Analysis and Insights: Global Mitochondrial Myopathies Market
The global Mitochondrial Myopathies market size is projected to reach US$ 27 million by 2026, from US$ 25 million in 2020, at a CAGR of 7.9%% during 2021-2026.
Global Mitochondrial Myopathies Scope and Market Size
Mitochondrial Myopathies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mitochondrial Myopathies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Reata Pharmaceuticals
Stealth Biotherapeutics
Raptor Pharmaceutical
Raym Genedx
Neurovive Pharmaceutical
…
Market segment by Type, the product can be split into
Muscle Biopsy
Blood Enzyme Test
Genetic Test
Market segment by Application, split into
Hospitals
Clinics
Disease Research and Development Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mitochondrial Myopathies Revenue
1.4 Market by Type
1.4.1 Global Mitochondrial Myopathies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Muscle Biopsy
1.4.3 Blood Enzyme Test
1.4.4 Genetic Test
1.5 Market by Application
1.5.1 Global Mitochondrial Myopathies Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Disease Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mitochondrial Myopathies Market Perspective (2015-2026)
2.2 Global Mitochondrial Myopathies Growth Trends by Regions
2.2.1 Mitochondrial Myopathies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mitochondrial Myopathies Historic Market Share by Regions (2015-2020)
2.2.3 Mitochondrial Myopathies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mitochondrial Myopathies Market Growth Strategy
2.3.6 Primary Interviews with Key Mitochondrial Myopathies Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mitochondrial Myopathies Players by Market Size
3.1.1 Global Top Mitochondrial Myopathies Players by Revenue (2015-2020)
3.1.2 Global Mitochondrial Myopathies Revenue Market Share by Players (2015-2020)
3.1.3 Global Mitochondrial Myopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mitochondrial Myopathies Market Concentration Ratio
3.2.1 Global Mitochondrial Myopathies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mitochondrial Myopathies Revenue in 2019
3.3 Mitochondrial Myopathies Key Players Head office and Area Served
3.4 Key Players Mitochondrial Myopathies Product Solution and Service
3.5 Date of Enter into Mitochondrial Myopathies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mitochondrial Myopathies Historic Market Size by Type (2015-2020)
4.2 Global Mitochondrial Myopathies Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mitochondrial Myopathies Market Size by Application (2015-2020)
5.2 Global Mitochondrial Myopathies Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mitochondrial Myopathies Market Size (2015-2020)
6.2 Mitochondrial Myopathies Key Players in North America (2019-2020)
6.3 North America Mitochondrial Myopathies Market Size by Type (2015-2020)
6.4 North America Mitochondrial Myopathies Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mitochondrial Myopathies Market Size (2015-2020)
7.2 Mitochondrial Myopathies Key Players in Europe (2019-2020)
7.3 Europe Mitochondrial Myopathies Market Size by Type (2015-2020)
7.4 Europe Mitochondrial Myopathies Market Size by Application (2015-2020)
8 China
8.1 China Mitochondrial Myopathies Market Size (2015-2020)
8.2 Mitochondrial Myopathies Key Players in China (2019-2020)
8.3 China Mitochondrial Myopathies Market Size by Type (2015-2020)
8.4 China Mitochondrial Myopathies Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mitochondrial Myopathies Market Size (2015-2020)
9.2 Mitochondrial Myopathies Key Players in Japan (2019-2020)
9.3 Japan Mitochondrial Myopathies Market Size by Type (2015-2020)
9.4 Japan Mitochondrial Myopathies Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mitochondrial Myopathies Market Size (2015-2020)
10.2 Mitochondrial Myopathies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mitochondrial Myopathies Market Size by Type (2015-2020)
10.4 Southeast Asia Mitochondrial Myopathies Market Size by Application (2015-2020)
11 India
11.1 India Mitochondrial Myopathies Market Size (2015-2020)
11.2 Mitochondrial Myopathies Key Players in India (2019-2020)
11.3 India Mitochondrial Myopathies Market Size by Type (2015-2020)
11.4 India Mitochondrial Myopathies Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mitochondrial Myopathies Market Size (2015-2020)
12.2 Mitochondrial Myopathies Key Players in Central & South America (2019-2020)
12.3 Central & South America Mitochondrial Myopathies Market Size by Type (2015-2020)
12.4 Central & South America Mitochondrial Myopathies Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Reata Pharmaceuticals
13.1.1 Reata Pharmaceuticals Company Details
13.1.2 Reata Pharmaceuticals Business Overview
13.1.3 Reata Pharmaceuticals Mitochondrial Myopathies Introduction
13.1.4 Reata Pharmaceuticals Revenue in Mitochondrial Myopathies Business (2015-2020))
13.1.5 Reata Pharmaceuticals Recent Development
13.2 Stealth Biotherapeutics
13.2.1 Stealth Biotherapeutics Company Details
13.2.2 Stealth Biotherapeutics Business Overview
13.2.3 Stealth Biotherapeutics Mitochondrial Myopathies Introduction
13.2.4 Stealth Biotherapeutics Revenue in Mitochondrial Myopathies Business (2015-2020)
13.2.5 Stealth Biotherapeutics Recent Development
13.3 Raptor Pharmaceutical
13.3.1 Raptor Pharmaceutical Company Details
13.3.2 Raptor Pharmaceutical Business Overview
13.3.3 Raptor Pharmaceutical Mitochondrial Myopathies Introduction
13.3.4 Raptor Pharmaceutical Revenue in Mitochondrial Myopathies Business (2015-2020)
13.3.5 Raptor Pharmaceutical Recent Development
13.4 Raym Genedx
13.4.1 Raym Genedx Company Details
13.4.2 Raym Genedx Business Overview
13.4.3 Raym Genedx Mitochondrial Myopathies Introduction
13.4.4 Raym Genedx Revenue in Mitochondrial Myopathies Business (2015-2020)
13.4.5 Raym Genedx Recent Development
13.5 Neurovive Pharmaceutical
13.5.1 Neurovive Pharmaceutical Company Details
13.5.2 Neurovive Pharmaceutical Business Overview
13.5.3 Neurovive Pharmaceutical Mitochondrial Myopathies Introduction
13.5.4 Neurovive Pharmaceutical Revenue in Mitochondrial Myopathies Business (2015-2020)
13.5.5 Neurovive Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Mitochondrial Myopathies Key Market Segments
Table 2. Key Players Covered: Ranking by Mitochondrial Myopathies Revenue
Table 3. Ranking of Global Top Mitochondrial Myopathies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mitochondrial Myopathies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Muscle Biopsy
Table 6. Key Players of Blood Enzyme Test
Table 7. Key Players of Genetic Test
Table 8. Global Mitochondrial Myopathies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Mitochondrial Myopathies Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Mitochondrial Myopathies Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Mitochondrial Myopathies Market Share by Regions (2015-2020)
Table 12. Global Mitochondrial Myopathies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Mitochondrial Myopathies Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Mitochondrial Myopathies Market Growth Strategy
Table 18. Main Points Interviewed from Key Mitochondrial Myopathies Players
Table 19. Global Mitochondrial Myopathies Revenue by Players (2015-2020) (Million US$)
Table 20. Global Mitochondrial Myopathies Market Share by Players (2015-2020)
Table 21. Global Top Mitochondrial Myopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathies as of 2019)
Table 22. Global Mitochondrial Myopathies by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Mitochondrial Myopathies Product Solution and Service
Table 25. Date of Enter into Mitochondrial Myopathies Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 28. Global Mitochondrial Myopathies Market Size Share by Type (2015-2020)
Table 29. Global Mitochondrial Myopathies Revenue Market Share by Type (2021-2026)
Table 30. Global Mitochondrial Myopathies Market Size Share by Application (2015-2020)
Table 31. Global Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 32. Global Mitochondrial Myopathies Market Size Share by Application (2021-2026)
Table 33. North America Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 35. North America Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 36. North America Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 37. North America Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 38. North America Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 39. Europe Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 41. Europe Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 43. Europe Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 45. China Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 46. China Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 47. China Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 48. China Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 49. China Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 50. China Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 51. Japan Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 53. Japan Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 55. Japan Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 59. Southeast Asia Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 61. Southeast Asia Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 63. India Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 64. India Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 65. India Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 66. India Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 67. India Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 68. India Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Mitochondrial Myopathies Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Mitochondrial Myopathies Market Share (2019-2020)
Table 71. Central & South America Mitochondrial Myopathies Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Mitochondrial Myopathies Market Share by Type (2015-2020)
Table 73. Central & South America Mitochondrial Myopathies Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Mitochondrial Myopathies Market Share by Application (2015-2020)
Table 75. Reata Pharmaceuticals Company Details
Table 76. Reata Pharmaceuticals Business Overview
Table 77. Reata Pharmaceuticals Product
Table 78. Reata Pharmaceuticals Revenue in Mitochondrial Myopathies Business (2015-2020) (Million US$)
Table 79. Reata Pharmaceuticals Recent Development
Table 80. Stealth Biotherapeutics Company Details
Table 81. Stealth Biotherapeutics Business Overview
Table 82. Stealth Biotherapeutics Product
Table 83. Stealth Biotherapeutics Revenue in Mitochondrial Myopathies Business (2015-2020) (Million US$)
Table 84. Stealth Biotherapeutics Recent Development
Table 85. Raptor Pharmaceutical Company Details
Table 86. Raptor Pharmaceutical Business Overview
Table 87. Raptor Pharmaceutical Product
Table 88. Raptor Pharmaceutical Revenue in Mitochondrial Myopathies Business (2015-2020) (Million US$)
Table 89. Raptor Pharmaceutical Recent Development
Table 90. Raym Genedx Company Details
Table 91. Raym Genedx Business Overview
Table 92. Raym Genedx Product
Table 93. Raym Genedx Revenue in Mitochondrial Myopathies Business (2015-2020) (Million US$)
Table 94. Raym Genedx Recent Development
Table 95. Neurovive Pharmaceutical Company Details
Table 96. Neurovive Pharmaceutical Business Overview
Table 97. Neurovive Pharmaceutical Product
Table 98. Neurovive Pharmaceutical Revenue in Mitochondrial Myopathies Business (2015-2020) (Million US$)
Table 99. Neurovive Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitochondrial Myopathies Market Share by Type: 2020 VS 2026
Figure 2. Muscle Biopsy Features
Figure 3. Blood Enzyme Test Features
Figure 4. Genetic Test Features
Figure 5. Global Mitochondrial Myopathies Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Disease Research and Development Institutes Case Studies
Figure 9. Mitochondrial Myopathies Report Years Considered
Figure 10. Global Mitochondrial Myopathies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Mitochondrial Myopathies Market Share by Regions: 2020 VS 2026
Figure 12. Global Mitochondrial Myopathies Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Mitochondrial Myopathies Market Share by Players in 2019
Figure 15. Global Top Mitochondrial Myopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathies as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Mitochondrial Myopathies Revenue in 2019
Figure 17. North America Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Mitochondrial Myopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…- シトクロムP450 11B2ミトコンドリアの世界市場（～2026年） Market Analysis and Insights: Global Cytochrome P450 11B2 Mitochondrial Market The global Cytochrome P450 11B2 Mitochondrial market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cytochrome P450 11B2 Mitochondrial Scope and …
- 肝炎診断検査の世界市場（～2026年） Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period.…
- 肝炎検査ソリューションの世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- 出生前遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prenatal Genetic Testing Scope and Market Size Prenatal Genetic T…